Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 866 402 4033

Clinical Trials News

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


August 17th, 2009
Saphris Sublingual Tabs Receives FDA Endorsement

The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.

August 13th, 2009
Top-Line Results From Zelrix Phase III, Clinical Trials

Specialty pharmaceutical company, who specializes in the generation of revolutionary products to treat neurological and psychiatric diseases, publicizes top-line results from the Phase III Zelrix clinical tria

August 11th, 2009
International Experts Issue Lantus Statement

Sanofi-aventis recently publicized the release of an Expert Statement issued by a board of multidisciplinary, internationally acclaimed experts, which follows an in-depth evaluation of the recent publications of registry analyses with Lantus in Diabetologia.

August 11th, 2009
Safety Concerns Cease NHLBI’s Sickle Cell, Pulmonary Hypertension Trial

The National Heart, Lung and Blood Institute (NHLBI) has halted a clinical trial involving drug treatment tests for pulmonary hypertension in adults who suffer from sickle cell disease.

August 11th, 2009
Array Publicizes Oral Glucokinase Activator Outcomes in Type 2 Diabetes Patients

Array BioPharma Inc. has recently notified the public of their Phase 1 favorable top-line data clinical trial, conducted with a group Type 2 diabetes patients and their small molecule glucokinase activator (GKA), ARRY-403

August 7th, 2009
Baxter Completes CELVAPAN A/H1N1 Pandemic Vaccine

Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.

August 7th, 2009
US FDA Supports Antipsychotic Once-Monthly Invega Sustenna

The US FDA has recently approved Invega Sustenna extended-release injectable suspension for acute and maintenance therapy of adult schizophrenia. Invega Sustenna is the first US approved once a month injectable, long-acting, atypical antipsychotic.

August 7th, 2009
Chinese Research Group Creates Healthy, Fertile Mice From Adult Stem Cells

The mouse is aptly named “Tiny” but his small stature has nothing to do with the large effect this pocket-size rodent is having on the science community, and the world for that matter!

August 7th, 2009
Vaxine Conducts The First Human Swine Flu Vaccine Immunization Trials

The Southern Australian biotech company: Vaxine Pty. Ltd., will be the first to administer a human swine flu vaccine immunization.

August 7th, 2009
Antiretroviral HIV Drugs Supply Breast-Fed Babies With Safety

Antiretroviral drugs are proving to be safe and helpful, thanks to an international study that examined HIV transmission prevention between mother and child by way of breast milk.


Search for Medication or Types of Conditions



: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

download order form


Medicine Shoppe Pharmacy
148 #9 31205 Maclure Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan


TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930